- Home
- BHV vs AXDX Comparison
BHV vs AXDX Comparison
Compare BHV & AXDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHV
- AXDX
- Stock Information
- Founded
- BHV 2002
- AXDX 1982
- Country
- BHV United States
- AXDX United States
- Employees
- BHV N/A
- AXDX N/A
- Industry
- BHV Finance/Investors Services
- AXDX Biotechnology: Laboratory Analytical Instruments
- Sector
- BHV Finance
- AXDX Industrials
- Exchange
- BHV Nasdaq
- AXDX Nasdaq
- Market Cap
- BHV 17.1M
- AXDX 13.7M
- IPO Year
- BHV N/A
- AXDX 1996
- Fundamental
- Price
- BHV $10.34
- AXDX $0.03
- Analyst Decision
- BHV
- AXDX
- Analyst Count
- BHV 0
- AXDX 0
- Target Price
- BHV N/A
- AXDX N/A
- AVG Volume (30 Days)
- BHV 3.5K
- AXDX 2.5M
- Earning Date
- BHV 01-01-0001
- AXDX 05-20-2025
- Dividend Yield
- BHV 3.35%
- AXDX N/A
- EPS Growth
- BHV N/A
- AXDX N/A
- EPS
- BHV N/A
- AXDX N/A
- Revenue
- BHV N/A
- AXDX $11,698,000.00
- Revenue This Year
- BHV N/A
- AXDX $7.25
- Revenue Next Year
- BHV N/A
- AXDX N/A
- P/E Ratio
- BHV N/A
- AXDX N/A
- Revenue Growth
- BHV N/A
- AXDX N/A
- 52 Week Low
- BHV $8.85
- AXDX $0.12
- 52 Week High
- BHV $12.08
- AXDX $2.09
- Technical
- Relative Strength Index (RSI)
- BHV 45.02
- AXDX 13.15
- Support Level
- BHV $10.35
- AXDX $0.12
- Resistance Level
- BHV $10.43
- AXDX $0.56
- Average True Range (ATR)
- BHV 0.10
- AXDX 0.05
- MACD
- BHV 0.02
- AXDX -0.04
- Stochastic Oscillator
- BHV 71.70
- AXDX 0.54
About BHV BlackRock Virginia Municipal Bond Trust
Blackrock Virginia Municipal Bond Trust is a perpetual closed-end municipal bond fund. Its objective is to provide current income exempt from regular Federal income taxes and Virginia personal income taxes. The company invests on behalf of its clients from large institutions to parents and grandparents, teachers, nurses, doctors and people from all walks of life who entrust their savings to the company.
About AXDX Accelerate Diagnostics Inc.
Accelerate Diagnostics Inc is an in vitro diagnostics company dedicated to providing solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. Its Clinical Microbiology products include Accelerate Pheno system, Accelerate PhenoTest BC Kit, and Accelerate Arc module & BC kit. The company earns the majority of its revenue from the domestic market. The group operates as one operating segment, deriving instrument, consumable, and service revenues from customers engaged in healthcare diagnostics within the United States. Product revenue is derived from the sale or rental of instruments and sales of related consumable products. Service revenue is derived from the sale of extended service agreements.